Irma Bagdoniene on NEJM-Published VESALIUS-CV: 25% Fewer First CV Events
Irma Bagdoniene, Cardiologist and Lipidologist at Klinikum Lippe – University Hospital for Cardiology, Angiology, and Internal Intensive Care Medicine, posted on LinkedIn:
”VESALIUS-CV at AHA:
The Room Was Applauding – And Not Without Reason
Presented at the AHA Congress and now published in NEJM, VESALIUS-CV marks a turning point in preventive cardiology.
In patients without prior MI or stroke, evolocumab reduced first major cardiovascular events by 25% — safely and decisively.
LDL lowering works – and earlier intervention saves lives.
When an entire audience of cardiologists applauds, it’s not hype. It’s the sound of a paradigm shifting.”
Read the full article here.
Title: Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
Authors: Erin A. Bohula, D.Phil., Nicholas A. Marston, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Julia F. Kuder, Sabina A. Murphy, Emileigh Walsh, Huei Wang, Vladimir Blaha, Andrzej Budaj, Jan H. Cornel, Assen Goudev, Robert Gabor Kiss, Alberto J. Lorenzatti, Alexander Parkhomenko, Marcoli Cyrille, Gabriel Paiva da Silva Lima, E. Magnus Ohman, Robert P. Giugliano, Marc S. Sabatine

Stay updated with Hemostasis Today.
-
Apr 8, 2026, 18:14Simon Fletcher: See The Unique Challenges PwH Face During Their Gene Therapy Journey
-
Apr 8, 2026, 17:56Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
-
Apr 8, 2026, 17:46Mohamed Reda: Why Some Veins Decide to Take a ‘Detour’?
-
Apr 8, 2026, 17:39Managing Acquired Von Willebrand Syndrome in a Swine Polytrauma Model During ECLS – JTH
-
Apr 8, 2026, 17:04Heghine Khachatryan: Marfan vs LDS – Not All Aortopathies Are the Same
-
Apr 8, 2026, 17:00Frits Rosendaal Receives ISTH Grant Medal for Lifetime Contributions to Thrombosis and Hemostasis Field
-
Apr 8, 2026, 16:25Xiaoying Chen: Teleneurological Ward As A Practical Way to Support High-Quality Stroke Care Beyond Major Centres
-
Apr 8, 2026, 16:24Ney Carter Borges: Endocrine Drivers of Resistant Hypertension – Insights from the MOMENTUM Trial at ACC 26
-
Apr 8, 2026, 16:21Jonathan Gelber: Exploring Papaya Extract as an Option to Elevate Platelet Numbers Before PRP